Chronic hepatitis C and normal ALT: considerations for treatment (Q45031712)

8 December 2017

title

Chronic hepatitis C and normal ALT: considerations for treatment (English)

1 reference

8 December 2017

1 reference

Bruce R Bacon

1

1 reference

8 December 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

The American Journal of Gastroenterology

8 December 2017

published in

1 reference

8 December 2017

volume

99

1 reference

8 December 2017

issue

9

1 reference

8 December 2017

page(s)

1706-1707

1 reference

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40627.X

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40627.X

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40627.X

Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40627.X

Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40627.X

Therapy of hepatitis C: patients with normal aminotransferase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.40627.X

10.1111/J.1572-0241.2004.40627.X

21 January 2018

Identifiers

DOI

1 reference

8 December 2017

1 reference